Ethinyloestradiol News

Warner Chilcott and Watson Pharmaceuticals Announce Launch of Zenchent®

Under a supply agreement between Warner Chilcott and Watson Pharma, Inc., Watson has launched Zenchent® (norethindrone and ethinyl estradiol tablets USP).

Galen Announces Agreement Resolving Outstanding Patent Challenges on Estrostep® and femhrt® with Bar

Craigavon - Galen Holdings PLC (“Galen”) today announced that it has completed an agreement under which Galen and Barr Pharmaceuticals Inc’s subsidiary, Barr Laboratories, Inc. (“Barr”), have agreed to settle the pending patent...

New HRT Drug Relieves Postmenopausal Symptoms With Less Bleeding

New York — Activella, a new hormone replacement therapy (HRT), relieves postmenopausal symptoms with less bleeding and spotting than Prempro, and with a more beneficial effect on lipid profiles. Results of a multicenter,...

Hormone Battle: Prempro vs. Activella

A new hormone replacement therapy (HRT) for menopause causes less bleeding than Prempro, the most-prescribed HRT.

Displaying results 1 to 5 out of 6

1

2

Next >

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.